Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens

OBJECTIVES: South Africa’s national antiretroviral (ARV) treatment program expanded in 2010 to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for adults and abacavir (ABC) for children. We investigated the associated changes in genotypic drug resistance patterns...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Zyl, Gert U., Liu, Tommy F., Claassen, Mathilda, Engelbrecht, Susan, de Oliveira, Tulio, Preiser, Wolfgang, Wood, Natasha T., Travers, Simon, Shafer, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694021/
https://www.ncbi.nlm.nih.gov/pubmed/23840622
http://dx.doi.org/10.1371/journal.pone.0067188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694021/
https://www.ncbi.nlm.nih.gov/pubmed/23840622
http://dx.doi.org/10.1371/journal.pone.0067188

Ejemplares similares